Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment
Improving Breast Cancer Patients' Self-Efficacy and Sexual Health Quality of Life
1 other identifier
interventional
200
1 country
4
Brief Summary
Approximately 200 English- or Spanish-speaking women newly diagnosed with stage I-III breast cancer will be randomized to either receive access to an online sexual health video series or receive usual care. Participants will complete surveys at baseline and every two months for six months, measuring self-efficacy in patient-provider communication and perceived barriers to discussing sexual health. Electronic health record review will assess utilization of sexual-health-related medical and supportive services. A subset of participants will participate in qualitative interviews to explore their sexual health experiences during treatment and, for those receiving the intervention, the perceived impact of the videos.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2027
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedStudy Start
First participant enrolled
January 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
Study Completion
Last participant's last visit for all outcomes
January 1, 2028
February 27, 2026
February 1, 2026
1 year
February 19, 2026
February 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Participant self-efficacy discussing sexual health with breast cancer providers
Changes in participant self-efficacy to discuss sexual health with breast cancer providers will be assessed using the Perceived Efficacy in Patient-Physician Interactions (PEPPI-5), administered at enrollment and every two months over a six-month period. The PEPPI-5 is a 5-item measure scored on a 5-point Likert scale, with higher scores indicating greater perceived self-efficacy in communicating with healthcare providers.
Baseline, 2 months, 4 months, 6 months
Perceived barriers to discussing sexual health with breast cancer providers
Measured using the 13-item Barriers to Sexual Health Communication (BSHC) scale. Items are rated on a 5-point Likert scale; higher scores reflect greater perceived communication barriers.
Baseline, 2 months, 4 months, 6 months
Secondary Outcomes (2)
Use of medical and supportive services outside of treatment-plan related visits
12 months
Qualitative measure: Patient-reported experiences with sexual health and perceived impact of the video content.
One time, 60 minute interview, 6-12 months after enrollment
Study Arms (2)
Intervention Arm
EXPERIMENTALParticipants receive access to the sexual-health educational video series.
Control Arm
PLACEBO COMPARATORParticipants receive standard care
Interventions
Participants randomized to the intervention arm will receive multiprong access to the videos, including a link provided through email and the recruitment sites' patients portal, a QR code, and tablets available in each clinic.
Eligibility Criteria
You may qualify if:
- Provision to sign and date the consent form.
- Stated willingness to comply with all study procedures and be available for the duration of the study.
- Age minimum 18
- Be a female as assigned on birth certificate
- Ability to read and speak English or Spanish
- A recent diagnosis of Stage 1-III invasive breast cancer and receiving treatment for breast cancer at the University of Colorado or Denver Health breast center(s).
You may not qualify if:
- Age less than 18 years old
- Stage 0 or Stage IV breast cancer
- Prior breast cancer diagnosis
- Non-breast cancer diagnoses
- Prior exposure to anti-hormone therapy, chemotherapy, or radiotherapy not related to breast cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Colorado, Denverlead
- Cancer League of Coloradocollaborator
Study Sites (4)
University of Colorado Hospital
Aurora, Colorado, 80045, United States
Denver Health Hospital and Clinic
Denver, Colorado, 80204, United States
UCHealth Cherry Creek Medical Center
Denver, Colorado, 80206, United States
UCHealth Highlands Ranch Hospital
Highlands Ranch, Colorado, 80129, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Tevis
University of Colorado, Denver
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2026
First Posted
February 27, 2026
Study Start (Estimated)
January 1, 2027
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2028
Last Updated
February 27, 2026
Record last verified: 2026-02